The store will not work correctly when cookies are disabled.
Phenyl-carbamic acid 5,10-dioxo-5,10-dihydro-benzo[g]quinolin-3-ylmethyl ester
ID: ALA441166
PubChem CID: 44385168
Max Phase: Preclinical
Molecular Formula: C21H14N2O4
Molecular Weight: 358.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1)OCc1cnc2c(c1)C(=O)c1ccccc1C2=O
Standard InChI: InChI=1S/C21H14N2O4/c24-19-15-8-4-5-9-16(15)20(25)18-17(19)10-13(11-22-18)12-27-21(26)23-14-6-2-1-3-7-14/h1-11H,12H2,(H,23,26)
Standard InChI Key: CMZPKPSTDVODOD-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
3.7042 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7042 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 0.9208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2542 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2667 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4167 0.9125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5667 -1.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4167 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2792 -1.5625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -1.5667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 1.7458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1375 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5667 -2.8042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8542 -1.5667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1292 0.5083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8542 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9917 -1.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5500 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5500 0.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9917 -2.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7042 -1.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8375 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8375 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4167 -1.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7125 -3.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4250 -2.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 2 1 0
5 3 1 0
6 5 2 0
7 2 1 0
8 15 1 0
9 1 1 0
10 8 1 0
11 3 2 0
12 4 2 0
13 9 2 0
14 8 2 0
15 17 1 0
16 13 1 0
17 13 1 0
18 10 1 0
19 5 1 0
20 6 1 0
21 18 2 0
22 18 1 0
23 24 1 0
24 19 2 0
25 22 2 0
26 21 1 0
27 25 1 0
7 16 2 0
6 4 1 0
20 23 2 0
27 26 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 358.35 | Molecular Weight (Monoisotopic): 358.0954 | AlogP: 3.61 | #Rotatable Bonds: 3 |
Polar Surface Area: 85.36 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.03 | CX Basic pKa: 1.96 | CX LogP: 3.67 | CX LogD: 3.67 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.60 | Np Likeness Score: -0.30 |
References
1. Lee H, Hong S, Kim Y. (1996) Synthesis and in vitro evaluation of 3-substituted-1-azaanthraquinones, 6 (8): [10.1016/0960-894X(96)00156-4] |